Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of vaginal, sublingual, and buccal misoprostol for labor induction at term
IRCT20180121038465N1Phase 2Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Mar 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of misoprostol (3 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Best, least expensive, most effective, and least complicated therapy for induction of childbirth, Effect of misoprostol by route of administration and 4 more. Started Mar 2018; status: completed.
02
Drugs
misoprostol
Beyond the preview
Go deeper on IRCT20180121038465N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180121038465N1.